Development and implementation of the IPCS conceptual framework for evaluating mode of action of chemical carcinogens

Toxicology

Volumn 181-182, Issue , 2002, Pages 121-125

  Dybing, Erik ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Cancer; Mechanism; Risk

Indexed keywords

ALPHA 2U GLOBULIN; CARCINOGEN; LIMONENE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; SACCHARIN SODIUM; SULFADIMIDINE; THYROID HORMONE;

BLADDER CARCINOMA; BLADDER DISEASE; CARCINOGENESIS; CELL PROLIFERATION; EROSION; EVALUATION; HOMEOSTASIS; HYPERPLASIA; KIDNEY CARCINOMA; LIVER CARCINOMA; LIVER CELL; NONHUMAN; PEROXISOME; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVIEW; THYROID FOLLICULAR CARCINOMA;

ANIMALIA;

EID: 0037184848     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(02)00266-4     Document Type: Article

References (4)

1. IARC, 1999. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Some Chemicals that Cause Tumours of the Kidney or Urinary Bladder in Rodents and Some Other Substances, Vol. 73, IARC, Lyon, France.
2. IARC, 2000. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Some Industrial Chemicals, Vol. 77, IARC, Lyon, France.
3. IARC, 2001. IARC Monographs on the Evaluation of Carcinogencic Riskst Humans. Some Thyreotropic Agents, Vol. 79, IARC, Lyon, France.
4. IPCS, 1999. IPCS Harmonization Workshop - Conceptual Framework for Cancer Risk Assessment, IARC, Lyon, France, 16-18 February 1999, IPCS/99.6.